ACADIA Pharmaceuticals (ACAD) Revenue & Revenue Breakdown
ACADIA Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$726.44M
Latest Revenue (Q)
$241.96M
Main Segment (Y)
Product
Main Geography (Y)
Product
ACADIA Pharmaceuticals Revenue by Period
ACADIA Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $726.44M | 40.45% |
| 2022-12-31 | $517.24M | 6.83% |
| 2021-12-31 | $484.14M | 9.60% |
| 2020-12-31 | $441.75M | 30.28% |
| 2019-12-31 | $339.08M | 51.50% |
| 2018-12-31 | $223.81M | 79.19% |
| 2017-12-31 | $124.90M | 620.68% |
| 2016-12-31 | $17.33M | 28311.48% |
| 2015-12-31 | $61.00K | -49.17% |
| 2014-12-31 | $120.00K | -89.52% |
| 2013-12-31 | $1.15M | -76.67% |
| 2012-12-31 | $4.91M | 137.40% |
| 2011-12-31 | $2.07M | -95.09% |
| 2010-12-31 | $42.13M | 558.46% |
| 2009-12-31 | $6.40M | 302.45% |
| 2008-12-31 | $1.59M | -78.95% |
| 2007-12-31 | $7.55M | -7.11% |
| 2006-12-31 | $8.13M | -25.77% |
| 2005-12-31 | $10.96M | 137.96% |
| 2004-12-31 | $4.60M | -37.60% |
| 2003-12-31 | $7.38M | 17.57% |
| 2002-12-31 | $6.28M | 68.97% |
| 2001-12-31 | $3.71M | -13.87% |
| 2000-12-31 | $4.31M | - |
ACADIA Pharmaceuticals generated $726.44M in revenue during NA 2023, up 40.45% compared to the previous quarter, and up 324.58% compared to the same period a year ago.
ACADIA Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $241.96M | 17.55% |
| 2024-03-31 | $205.83M | -10.91% |
| 2023-12-31 | $231.04M | 9.14% |
| 2023-09-30 | $211.70M | 28.12% |
| 2023-06-30 | $165.24M | 39.48% |
| 2023-03-31 | $118.46M | -13.21% |
| 2022-12-31 | $136.49M | 4.42% |
| 2022-09-30 | $130.71M | -2.86% |
| 2022-06-30 | $134.56M | 16.54% |
| 2022-03-31 | $115.47M | -11.69% |
| 2021-12-31 | $130.76M | -0.65% |
| 2021-09-30 | $131.61M | 14.23% |
| 2021-06-30 | $115.22M | 8.13% |
| 2021-03-31 | $106.55M | -11.94% |
| 2020-12-31 | $121.01M | 0.36% |
| 2020-09-30 | $120.58M | 9.51% |
| 2020-06-30 | $110.10M | 22.24% |
| 2020-03-31 | $90.07M | -8.40% |
| 2019-12-31 | $98.33M | 3.95% |
| 2019-09-30 | $94.59M | 13.68% |
| 2019-06-30 | $83.20M | 32.16% |
| 2019-03-31 | $62.96M | 5.69% |
| 2018-12-31 | $59.57M | 2.17% |
| 2018-09-30 | $58.30M | 2.18% |
| 2018-06-30 | $57.06M | 16.77% |
| 2018-03-31 | $48.87M | 12.18% |
| 2017-12-31 | $43.56M | 22.44% |
| 2017-09-30 | $35.58M | 16.74% |
| 2017-06-30 | $30.48M | 99.37% |
| 2017-03-31 | $15.29M | 27.79% |
| 2016-12-31 | $11.96M | 127.07% |
| 2016-09-30 | $5.27M | 5330.93% |
| 2016-06-30 | $97.00K | 2325.00% |
| 2016-03-31 | $4.00K | -76.47% |
| 2015-12-31 | $17.00K | -56.41% |
| 2015-09-30 | $39.00K | 3800.00% |
| 2015-06-30 | $1.00K | -75.00% |
| 2015-03-31 | $4.00K | -91.67% |
| 2014-12-31 | $48.00K | 220.00% |
| 2014-09-30 | $15.00K | -46.43% |
| 2014-06-30 | $28.00K | -6.67% |
| 2014-03-31 | $30.00K | -18.92% |
| 2013-12-31 | $37.00K | -84.58% |
| 2013-09-30 | $240.00K | -46.78% |
| 2013-06-30 | $451.00K | 8.15% |
| 2013-03-31 | $417.00K | 9.74% |
| 2012-12-31 | $380.00K | -89.07% |
| 2012-09-30 | $3.48M | 480.63% |
| 2012-06-30 | $599.00K | 33.11% |
| 2012-03-31 | $450.00K | -23.47% |
| 2011-12-31 | $588.00K | 0.68% |
| 2011-09-30 | $584.00K | 26.96% |
| 2011-06-30 | $460.00K | 5.75% |
| 2011-03-31 | $435.00K | -98.77% |
| 2010-12-31 | $35.40M | 1438.64% |
| 2010-09-30 | $2.30M | 0.17% |
| 2010-06-30 | $2.30M | 7.69% |
| 2010-03-31 | $2.13M | 20.58% |
| 2009-12-31 | $1.77M | -27.35% |
| 2009-09-30 | $2.44M | 33.79% |
| 2009-06-30 | $1.82M | 386.63% |
| 2009-03-31 | $374.00K | 15.08% |
| 2008-12-31 | $325.00K | 15.25% |
| 2008-09-30 | $282.00K | 59.32% |
| 2008-06-30 | $177.00K | -78.04% |
| 2008-03-31 | $806.00K | -49.08% |
| 2007-12-31 | $1.58M | - |
ACADIA Pharmaceuticals generated $241.96M in revenue during Q2 2024, up 17.55% compared to the previous quarter, and up 204.25% compared to the same period a year ago.
ACADIA Pharmaceuticals Revenue Breakdown
ACADIA Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 18 |
|---|---|
| Product | $223.81M |
ACADIA Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 18: Product (100.00%).
ACADIA Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 18 |
|---|---|
| Product | $223.81M |
ACADIA Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 18: Product (100.00%).
ACADIA Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRPT | Sarepta Therapeutics | $1.24B | $413.46M |
| PTCT | PTC Therapeutics | $937.82M | $186.70M |
| ACAD | ACADIA Pharmaceuticals | $726.44M | $241.96M |
| BPMC | Blueprint Medicines | $249.38M | $138.16M |
| FBIO | Fortress Biotech | $59.66M | $13.03M |
| KRYS | Krystal Biotech | $50.70M | $70.28M |
| CABA | Cabaletta Bio | - | - |
| VKTX | Viking Therapeutics | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| ATHA | Athira Pharma | - | - |
| MDGL | Madrigal Pharmaceuticals | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| AKRO | Akero Therapeutics | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |
ACAD Revenue FAQ
What is ACADIA Pharmaceuticals’s yearly revenue?
ACADIA Pharmaceuticals's yearly revenue for 2023 was $726.44M, representing an increase of 40.45% compared to 2022. The company's yearly revenue for 2022 was $517.24M, representing an increase of 6.83% compared to 2021. ACAD's yearly revenue for 2021 was $484.14M, representing an increase of 9.60% compared to 2020.
What is ACADIA Pharmaceuticals’s quarterly revenue?
ACADIA Pharmaceuticals's quarterly revenue for Q2 2024 was $241.96M, a 17.55% increase from the previous quarter (Q1 2024), and a 46.44% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $205.83M, a -10.91% decrease from the previous quarter (Q4 2023), and a 73.75% increase year-over-year (Q1 2023). ACAD's quarterly revenue for Q4 2023 was $231.04M, a 9.14% increase from the previous quarter (Q3 2023), and a 69.27% increase year-over-year (Q4 2022).
What is ACADIA Pharmaceuticals’s revenue growth rate?
ACADIA Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 50.05%, and for the last 5 years (2019-2023) was 114.24%.
What are ACADIA Pharmaceuticals’s revenue streams?
ACADIA Pharmaceuticals's revenue streams in c 18 are Product
What is ACADIA Pharmaceuticals’s main source of revenue?
For the fiscal year ending Dec 18, the largest source of revenue of ACADIA Pharmaceuticals was Product. This segment made a revenue of $223.81M, representing 100.00% of the company's total revenue.